EPHA2 and pancreatic neoplasm: In pancreatic cancer, EphA2 expression is dramatically inversely correlated with survival [9,21], and the detection of EphA2 fragments in plasma has been recently proposed as a new possible diagnostic approach to anticipate the aggressiveness of pancreatic cancer in patients [22].